In the context of HCC, epigenetic therapies aimed at reversing GSTP1 hypermethylation could enhance the cellular detoxification capacity and reduce tumor progression by reactivating the silenced GSTP1 gene (Jain et al., 2012b). The gene discussed is GSTP1; the disease is hepatocellular carcinoma.